This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Scinnohub Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Dewei Zhang - Innovator in Pharmaceutical Science
Introduction
Dewei Zhang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical science, particularly in the area of coagulation and hemostatic activity.
Latest Patents
Zhang holds a patent for a plasmin inhibitor, which includes a preparation method and its applications. This compound, represented by a specific formula, is capable of inhibiting plasmin activity, thereby delaying fibrinolysis. It also possesses coagulation and hemostatic properties, along with pharmaceutically acceptable salts, hydrates, isomers, prodrugs, and mixtures thereof.
Career Highlights
Zhang is currently employed at Scinnohub Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work focuses on innovative solutions in the pharmaceutical industry, contributing to the development of new therapeutic agents.
Collaborations
Zhang collaborates with talented colleagues, including Anle Yang and Sen Ji, who share his commitment to advancing pharmaceutical research.
Conclusion
Dewei Zhang's innovative work in the field of pharmaceutical science, particularly with his plasmin inhibitor patent, showcases his dedication to improving health outcomes through scientific advancements. His contributions are valuable to the ongoing development of effective therapeutic solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile